ES2723598T3 - Composition for the prevention or treatment of ovarian polycystosis and its related symptoms - Google Patents
Composition for the prevention or treatment of ovarian polycystosis and its related symptoms Download PDFInfo
- Publication number
- ES2723598T3 ES2723598T3 ES16197205T ES16197205T ES2723598T3 ES 2723598 T3 ES2723598 T3 ES 2723598T3 ES 16197205 T ES16197205 T ES 16197205T ES 16197205 T ES16197205 T ES 16197205T ES 2723598 T3 ES2723598 T3 ES 2723598T3
- Authority
- ES
- Spain
- Prior art keywords
- prevention
- treatment
- composition
- related symptoms
- polycystosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- External Artificial Organs (AREA)
- Apparatus For Radiation Diagnosis (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composición que comprende i) ácido corosólico, elagitaninos y/o un extracto de Banaba (Lagerstroemia speciosa), ii) inositol y/o sus sales y/o formas isómeras, iii) Ipomoea Batatas y un vehículo fisiológicamente aceptable, para uso en la prevención y/o tratamiento del síndrome de ovario poliquístico.Composition comprising i) corosolic acid, elagitannins and / or an extract of Banaba (Lagerstroemia speciosa), ii) inositol and / or its salts and / or isomeric forms, iii) Ipomoea Batatas and a physiologically acceptable vehicle, for use in prevention and / or treatment of polycystic ovary syndrome.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITUB2015A005087A ITUB20155087A1 (en) | 2015-11-05 | 2015-11-05 | COMPOSITION TO PREVENT OR TREAT THE POLYCHISTIC OVAR SYNDROME AND RELATED SYMPTOMS |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2723598T3 true ES2723598T3 (en) | 2019-08-29 |
Family
ID=55410033
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES16197205T Active ES2723598T3 (en) | 2015-11-05 | 2016-11-04 | Composition for the prevention or treatment of ovarian polycystosis and its related symptoms |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP3165229B8 (en) |
DK (1) | DK3165229T3 (en) |
ES (1) | ES2723598T3 (en) |
HR (1) | HRP20190676T1 (en) |
HU (1) | HUE043246T2 (en) |
IT (1) | ITUB20155087A1 (en) |
LT (1) | LT3165229T (en) |
PL (1) | PL3165229T3 (en) |
PT (1) | PT3165229T (en) |
RS (1) | RS58661B1 (en) |
SI (1) | SI3165229T1 (en) |
TR (1) | TR201906364T4 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITUA20163025A1 (en) * | 2016-04-29 | 2017-10-29 | Sochim Int S P A | COMPOSITION FOR THE TREATMENT OF THE POLICISTIC OVARIAN SYNDROME |
CN117164686B (en) * | 2022-05-11 | 2024-05-31 | 中国农业大学 | Stress-resistance related protein IbRCD1, related biological material and application thereof |
CN115282176A (en) * | 2022-08-24 | 2022-11-04 | 北京彩晔健康管理有限公司 | Composition for delaying ovarian aging and improving polycystic ovarian syndrome and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070108161A (en) * | 2004-12-22 | 2007-11-08 | 르네상스 허브즈 인코포레이티드 | Pharmaceutical, therapeutic, and dietary compositions derived from lagerstroemia speciosa l. plant |
US8349373B1 (en) * | 2011-07-25 | 2013-01-08 | Conrad Anton Smith | Dietary supplement for use in a weight loss program |
CN102631516A (en) * | 2012-05-02 | 2012-08-15 | 马守云 | Medicament for treating infertility |
-
2015
- 2015-11-05 IT ITUB2015A005087A patent/ITUB20155087A1/en unknown
-
2016
- 2016-11-04 DK DK16197205.4T patent/DK3165229T3/en active
- 2016-11-04 PL PL16197205T patent/PL3165229T3/en unknown
- 2016-11-04 HU HUE16197205A patent/HUE043246T2/en unknown
- 2016-11-04 TR TR2019/06364T patent/TR201906364T4/en unknown
- 2016-11-04 LT LTEP16197205.4T patent/LT3165229T/en unknown
- 2016-11-04 RS RS20190521A patent/RS58661B1/en unknown
- 2016-11-04 PT PT16197205T patent/PT3165229T/en unknown
- 2016-11-04 EP EP16197205.4A patent/EP3165229B8/en active Active
- 2016-11-04 ES ES16197205T patent/ES2723598T3/en active Active
- 2016-11-04 SI SI201630245T patent/SI3165229T1/en unknown
-
2019
- 2019-04-10 HR HRP20190676TT patent/HRP20190676T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ITUB20155087A1 (en) | 2017-05-05 |
PL3165229T3 (en) | 2019-08-30 |
HUE043246T2 (en) | 2019-08-28 |
DK3165229T3 (en) | 2019-05-13 |
EP3165229A1 (en) | 2017-05-10 |
RS58661B1 (en) | 2019-06-28 |
TR201906364T4 (en) | 2019-05-21 |
LT3165229T (en) | 2019-05-27 |
SI3165229T1 (en) | 2019-06-28 |
EP3165229B1 (en) | 2019-02-13 |
PT3165229T (en) | 2019-05-28 |
HRP20190676T1 (en) | 2019-05-31 |
EP3165229B8 (en) | 2019-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2017005626A2 (en) | A composition comprising bacteroides thetaiotaomicron | |
CL2018003754A1 (en) | Glucagon derivative, conjugate thereof, composition comprising the same and therapeutic use thereof. | |
CL2020002269A1 (en) | Fold-Binding Antibody33; polynucleotide; vector; host cell; method of producing the antibody; pharmaceutical composition; combination product; use of the antibody to treat an inflammatory condition (divisional application no. 201702433) | |
CL2018001790A1 (en) | Processes to prepare a jak1 inhibitor and new forms of this (divisional application 201602748) | |
CL2017003459A1 (en) | Cyclic sulfamoylarylamide derivatives and their use as medicines for the treatment of hepatitis b. | |
PH12018500894A1 (en) | Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab | |
ECSP19015192A (en) | COMPOSITIONS AND METHODS OF INHIBITING MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS | |
CL2020000632A1 (en) | Composition and method for the treatment of autism. | |
UY35984A (en) | NEW SALTS AND PHARMACEUTICAL COMPOSITIONS OF THE SAME FOR THE TREATMENT OF INFLAMMATORY DISORDERS. | |
ES2871036T3 (en) | Method for treating bile acid-related disorders | |
CR20170219A (en) | BROMODOMINUM INHIBITORS | |
CL2016001587A1 (en) | Derivative based on 1,2-naphthoquinone and method of preparation thereof. | |
CO2019008103A2 (en) | Pharmaceutical compositions for combination therapy | |
SV2017005412A (en) | COMPOUNDS OF 1-RENT-6-OXO-1,6-DIHIDROPIRIDIN-3-ILO AND USES OF THE SAME | |
CL2017001904A1 (en) | Composition for the treatment of hepatic veno-occlusive disease. | |
AR102790A1 (en) | ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS TO TREAT FOOD AND SURFACE PRODUCTS | |
CL2016002754A1 (en) | Treatment device and treatment procedure for pickling and phosphating metal parts | |
ES2723598T3 (en) | Composition for the prevention or treatment of ovarian polycystosis and its related symptoms | |
MX2016011938A (en) | Liquid pharmaceutical composition. | |
CL2017000563A1 (en) | Use of elsiglutide to treat gastrointestinal mucositis that includes chemotherapy-induced diarrhea. | |
DOP2017000085A (en) | STABILIZED DERIVATIVES OF ADRENOMEDULINE AND USE OF THE SAME | |
CL2021000930A1 (en) | Novel Pyridazines | |
DOP2017000065A (en) | FORMULATION THAT INCLUDES GLICOPIRROLATE, METHOD AND APPLIANCE | |
BR112019001024A2 (en) | combination of a bcl-2 inhibitor and a mcl-1 inhibitor, their uses and pharmaceutical compositions | |
BR112016015578A2 (en) | 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 AND TYPE 2 INHIBITORS |